Alveolar macrophages (AMs), upon sensing pathogens, trigger host defense by activating toll-like receptor 4 (TLR4), but the counterbalancing mechanisms that deactivate AM inflammatory signaling and prevent lethal edema, the hallmark of acute lung injury (ALI), remain unknown. Here, we demonstrate the essential role of AM protease-activating receptor 2 (PAR2) in rapidly suppressing inflammation to prevent long-lasting injury. We show that thrombin, released during TLR4-induced lung injury, directly activates PAR2 to generate cAMP, which abolishes Ca2+ entry through the TRPV4 channel. Deletion of PAR2 and thus the accompanying cAMP generation augments Ca2+ entry via TRPV4, causing sustained activation of the transcription factor NFAT to produce long-lasting TLR4-mediated inflammatory lung injury. Rescuing thrombin-sensitive PAR2 expression or blocking TRPV4 activity in PAR2-null AMs restores their capacity to resolve inflammation and reverse lung injury. Thus, activation of the thrombin-induced PAR2-cAMP cascade in AMs suppresses TLR4 inflammatory signaling to reinstate tissue integrity.
Pubmed ID: 30995477 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This unknown targets Phospho-NFATC1 (Ser294)
View all literature mentionsThis monoclonal targets β-Actin
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets CD170 (Siglec F)
View all literature mentionsThis polyclonal targets Rela
View all literature mentionsThis monoclonal targets Ly-6G/Ly-6C
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis polyclonal targets Rela
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets β-Actin
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis unknown targets Phospho-NFATC1 (Ser294)
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets Ly-6G/Ly-6C
View all literature mentionsThis monoclonal targets CD170 (Siglec F)
View all literature mentions